Concepedia

Stephen Orena

SO

Statistics

Publications

21

Citations

1.6K

H-Index

15

Active since

1986

Affiliations

Pfizer (United States)(Current)

Infectious Diseases Research Collaboration

University of California, San Francisco

Dominican University of California

Brown University

Stephen Orena is an author at Pfizer (United States) specializing in life sciences, cell signaling, and pharmacology.

Publications per year

1986–2025

21

Publications

21

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ

Robert S. Garofalo, Stephen Orena, Kristina Rafidi et al. · Journal of Clinical Investigation · 2003 · 712 citations · Full text

, , +17

Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda

Patrick K. Tumwebaze, Melissa D. Conrad, Martin Okitwi et al. · Nature Communications · 2022 · 146 citations · Full text

, , +15

Inhibition of Glycogen-synthase Kinase 3 Stimulates Glycogen Synthase and Glucose Transport by Distinct Mechanisms in 3T3-L1 Adipocytes

Stephen Orena, Anthony J. Torchia, Robert S. Garofalo · Journal of Biological Chemistry · 2000 · 108 citations · Full text

, , +16

Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass

Andrew G. Swick, Stephen Orena, Annalouise O’Connor · Metabolism · 2013 · 85 citations

, , +12

Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study

Patrick K. Tumwebaze, Thomas Katairo, Martin Okitwi et al. · The Lancet Microbe · 2021 · 77 citations · Full text

, , +17

1–5 of 21